These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15016726)

  • 21. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vitro model for discovery of osteoclast specific biomarkers towards identification of racehorses at risk for catastrophic fractures.
    Malek G; Richard H; Beauchamp G; Laverty S
    Equine Vet J; 2023 May; 55(3):534-550. PubMed ID: 35616632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
    Tang SJ; Meikle MC; MacLaine JK; Wong RW; Rabie BM
    Eur J Orthod; 2013 Apr; 35(2):169-74. PubMed ID: 22467569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
    Nakanishi M; Yoh K; Miura T; Ohasi T; Rai SK; Uchida K
    Clin Chem; 2000 Apr; 46(4):469-73. PubMed ID: 10759470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY; Wu YY; Janckila AJ
    Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study.
    Savarino L; Avnet S; Greco M; Giunti A; Baldini N
    J Orthop Res; 2010 Jul; 28(7):887-92. PubMed ID: 20063383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.
    Waguespack SG; Hui SL; White KE; Buckwalter KA; Econs MJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2212-7. PubMed ID: 11994366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.
    Chen CJ; Chao TY; Chu DM; Janckila AJ; Cheng SN
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):5-8. PubMed ID: 14707702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
    Del Fattore A; Fornari R; Van Wesenbeeck L; de Freitas F; Timmermans JP; Peruzzi B; Cappariello A; Rucci N; Spera G; Helfrich MH; Van Hul W; Migliaccio S; Teti A
    J Bone Miner Res; 2008 Mar; 23(3):380-91. PubMed ID: 17997709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of osteoclast activity in patients with sickle cell disease.
    Nouraie M; Cheng K; Niu X; Moore-King E; Fadojutimi-Akinsi MF; Minniti CP; Sable C; Rana S; Dham N; Campbell A; Ensing G; Kato GJ; Gladwin MT; Castro OL; Gordeuk VR
    Haematologica; 2011 Aug; 96(8):1092-8. PubMed ID: 21546502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
    Chu P; Chao TY; Lin YF; Janckila AJ; Yam LT
    Am J Kidney Dis; 2003 May; 41(5):1052-9. PubMed ID: 12722040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
    Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
    Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
    Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J; Izumi N; Kasahara H; Tagawa H; Chiba T; Nihei H
    Nihon Jinzo Gakkai Shi; 2010; 52(8):1022-8. PubMed ID: 21254698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRACP 5b and CTX as osteological markers of delayed fracture healing.
    Moghaddam A; Müller U; Roth HJ; Wentzensen A; Grützner PA; Zimmermann G
    Injury; 2011 Aug; 42(8):758-64. PubMed ID: 21168135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects.
    Nishizawa Y; Inaba M; Ishii M; Yamashita H; Miki T; Goto H; Yamada S; Chaki O; Kurasawa K; Mochizuki Y
    J Bone Miner Metab; 2008; 26(3):265-70. PubMed ID: 18470668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased osteoclast activity is associated with aggressiveness of osteosarcoma.
    Avnet S; Longhi A; Salerno M; Halleen JM; Perut F; Granchi D; Ferrari S; Bertoni F; Giunti A; Baldini N
    Int J Oncol; 2008 Dec; 33(6):1231-8. PubMed ID: 19020756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.
    Henriksen K; Gram J; Schaller S; Dahl BH; Dziegiel MH; Bollerslev J; Karsdal MA
    Am J Pathol; 2004 May; 164(5):1537-45. PubMed ID: 15111300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.